Cara Therapeutics | CARA - Interest Income


Cara Therapeutics reported $347K in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.99M 65K Jun/2026
Cara Therapeutics USD 347K 74K Mar/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Chugai Pharma JPY 42M 438M Mar/2026
Compugen USD 1.84M 699K Jun/2026
CSL USD 18M 1000K Dec/2024
J&J USD 0.09 2.18 Sep/2026
Pacira USD 2.5M 551K Sep/2026
Pfizer USD 0.56 0.6 Sep/2026
RedHill Biopharma USD 7.1M 14.49M Jun/2023
Supernus Pharmaceuticals USD 2.63M 248K Jun/2026